• Home
  • Ferrous iron-activatable drug conjugate achieves potent MAPK blockade in KRAS-driven tumors.

Ferrous iron-activatable drug conjugate achieves potent MAPK blockade in KRAS-driven tumors.

Author List
Jiang H, Muir RK, Gonciarz RL, Olshen AB, Yeh I, Hann BC, Zhao N, Wang YH, Behr SC, Korkola JE, Evans MJ, Collisson EA, Renslo AR
Publication
The Journal of experimental medicine
Publication ID (Profile URL)
https://researcherprofiles.org/profile/268703827
Publication Year
2022
PubMed ID
35262628
Publication Title
Jiang H, Muir RK, Gonciarz RL, Olshen AB, Yeh I, Hann BC, Zhao N, Wang YH, Behr SC, Korkola JE, Evans MJ, Collisson EA, Renslo AR. Ferrous iron-activatable drug conjugate achieves potent MAPK blockade in KRAS-driven tumors. J Exp Med. 2022 04 04; 219(4).